This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Focal adhesion kinase
From Proteopedia
(Difference between revisions)
| (7 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <StructureSection load='2jkk' size='350' side='right' scene='' caption='Focal adhesion kinase 1 kinase domain complex with pyrimidine derivative inhibitor and sulfate (PDB code [[2jkk]]) '> | + | <StructureSection load='2jkk' size='350' side='right' scene='48/480805/Cv/1' caption='Focal adhesion kinase 1 kinase domain complex with pyrimidine derivative inhibitor and sulfate (PDB code [[2jkk]]) '> |
| + | == Function == | ||
| - | For details on '''focal adhesion kinase or protein tyrosine kinase 2β (PTK2)''' see [[Molecular Playground/FAK]]<ref>PMID:15688067</ref>. | + | '''Focal adhesion kinase''' (FAK) is involved in cellular adhesion. During apoptosis, FAK is cleaved into 2 fragments. The smaller fragment is associated with death signaling. For details on '''focal adhesion kinase or protein tyrosine kinase 2β (PTK2)''' see [[Molecular Playground/FAK]]<ref>PMID:15688067</ref>. |
== Relevance == | == Relevance == | ||
| Line 9: | Line 10: | ||
== Structural insights == | == Structural insights == | ||
| - | FAK ATP-binding site is the location of inhibitor binding. | + | FAK ATP-binding site is the <scene name='48/480805/Cv/5'>location of inhibitor binding</scene><ref>PMID:19030106</ref>. |
| - | </StructureSection> | ||
== 3D Structures of focal adhesion kinase == | == 3D Structures of focal adhesion kinase == | ||
| + | [[Focal adhesion kinase 3D structures]] | ||
| - | + | </StructureSection> | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | *Focal adhesion kinase 2 (FAK2) See Pyk2 in [[Tyrosine kinase]] | ||
| - | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
| |||||||||||
References
- ↑ Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68. PMID:15688067 doi:http://dx.doi.org/10.1038/nrm1549
- ↑ Cabrita MA, Jones LM, Quizi JL, Sabourin LA, McKay BC, Addison CL. Focal adhesion kinase inhibitors are potent anti-angiogenic agents. Mol Oncol. 2011 Dec;5(6):517-26. doi: 10.1016/j.molonc.2011.10.004. Epub 2011 Oct, 20. PMID:22075057 doi:http://dx.doi.org/10.1016/j.molonc.2011.10.004
- ↑ Lietha D, Eck MJ. Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation. PLoS ONE. 2008;3(11):e3800. Epub 2008 Nov 24. PMID:19030106 doi:10.1371/journal.pone.0003800
